Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions

Stephen Burgess1, Daniel F Freitag1, Hassan Khan1

  • 1Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, Cambridgeshire, United Kingdom.

Plos One
|October 11, 2014
PubMed

Insights

High-density lipoprotein cholesterol (HDL-c) may be causally protective against coronary artery disease (CAD), independent of low-density lipoprotein cholesterol (LDL-c) and triglycerides. This finding suggests potential therapeutic benefits of targeting HDL-c for CAD risk reduction.

Area of Science:

  • Genetics
  • Cardiovascular Disease Epidemiology
  • Biochemistry

Background:

  • Previous studies suggested a causal role for LDL-c and triglycerides in CAD risk.
  • However, the causal link between HDL-c and CAD risk remained uncertain, with some evidence suggesting no significant association.

Purpose of the Study:

  • To investigate the independent causal effects of HDL-c, LDL-c, and triglycerides on coronary artery disease (CAD) risk.
  • To clarify the role of HDL-c in CAD etiology using advanced Mendelian randomization methods.

Main Methods:

  • Employed multivariable Mendelian randomization using published data.
  • Analyzed associations between 185 lipid-related genetic variants, lipid fractions (in 188,578 participants), and CAD risk (in 22,233 cases and 64,762 controls).
  • Focused on genetic variants without pleiotropic associations with blood pressure or BMI.

Main Results:

  • Multivariable Mendelian randomization indicated that HDL-c may be causally protective against CAD, independent of LDL-c and triglycerides.
  • Estimated odds ratios per standard deviation increase: LDL-c (1.57), HDL-c (0.91, p=0.028), triglycerides (1.29).
  • Results suggest HDL-c has an independent protective association with CAD risk.

Conclusions:

  • Interventions targeting HDL-c concentrations may influence CAD risk, though potentially to a lesser extent than LDL-c interventions.
  • The causal interpretation assumes no pleiotropic associations of genetic variants with other CAD risk factors.
  • Genetic predictors of LDL-c, HDL-c, and triglycerides demonstrate independent associations with CAD risk.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.3K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
113
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
835
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
152
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
3.7K